Aileron Therapeutics, Inc.(ALRN) a Boston-based biopharmaceutical company Friday has announced that it has rebranded itself into Rein Therapeutics, Inc. The updated name, logo, website, and branding represent the Company's mission to create breakthrough treatments to combat diseases.
ALRN's stock will start to trade under the Nasdaq ticker "RNTX" from January 13, 2025. The CUSIP number for the company's common stock remains unchanged.
Currently, is trading at $2.01 or 4.1451% higher on the Nasdaq Capital Market.
For comments and feedback: editorial@rttnews.com